XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.24.0.1

FINANCIAL HIGHLIGHTS (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2023
Investment Company [Abstract] |
Schedule of Investment Company, Financial Highlights |
| Three Months Ended December 31, |  | Nine Months Ended December 31,
| 2023 |  | 2022 |  | 2023 |  | 2022
Per Common Share Data: |  |  |  |  |  |  |
Net asset value at beginning of period(A) | $ | 14.03 |  |  | $ | 13.31 |  |  | $ | 13.09 |  |  | $ | 13.43 |
Income from investment operations(B) |  |  |  |  |  |  |
Net investment income | 0.28 |  |  | 0.26 |  |  | 0.49 |  |  | 0.82 |
Net realized gain | 1.27 |  |  | 0.11 |  |  | 1.32 |  |  | 0.32 |
Net unrealized (depreciation) appreciation | (1.36) |  |  | 0.10 |  |  | 0.04 |  |  | (0.21) |
Total from investment operations | 0.19 |  |  | 0.47 |  |  | 1.85 |  |  | 0.93 |
Effect of equity capital activity(B) |  |  |  |  |  |  |
Cash distributions to common stockholders from net investment income(C) | (0.43) |  |  | (0.22) |  |  | (0.84) |  |  | (0.46) |
Cash distributions to common stockholders from net realized gains(C) | (0.81) |  |  | (0.14) |  |  | (1.12) |  |  | (0.47) |
Discounts, commissions and offering costs | (0.01) |  |  | — |  |  | (0.01) |  |  | — |
Net accretive effective of equity offering(D) | 0.05 |  |  | 0.01 |  |  | 0.05 |  |  | 0.01 |
Total from equity capital activity | (1.20) |  |  | (0.35) |  |  | (1.92) |  |  | (0.92) |
Other, net(B)(E) | (0.01) |  |  | — |  |  | (0.01) |  |  | (0.01) |
Net asset value at end of period(A) | $ | 13.01 |  |  | $ | 13.43 |  |  | $ | 13.01 |  |  | $ | 13.43 |
Per common share market value at beginning of period | $ | 12.74 |  |  | $ | 12.10 |  |  | $ | 13.25 |  |  | $ | 16.13 |
Per common share market value at end of period | $ | 14.15 |  |  | $ | 12.91 |  |  | 14.15 |  |  | 12.91 |
Total investment return(F) | 20.85 | % |  | 9.63 | % |  | 22.72 | % |  | (14.36) | %
Common stock outstanding at end of period(A) | 35,351,954 |  |  | 33,447,001 |  |  | 35,351,954 |  |  | 33,447,001 |
Statement of Assets and Liabilities Data: |  |  |  |  |  |  |
Net assets at end of period | $ | 459,941 |  |  | $ | 449,191 |  |  | $ | 459,941 |  |  | $ | 449,191 |
Average net assets(G) | $ | 475,007 |  |  | $ | 445,431 |  |  | 455,627 |  |  | 446,742 |
Senior Securities Data: |  |  |  |  |  |  |
Total borrowings, at cost | $ | 419,838 |  |  | $ | 292,088 |  |  | $ | 419,838 |  |  | $ | 292,088 |
Ratios/Supplemental Data: |  |  |  |  |  |  |
Ratio of net expenses to average net assets – annualized(H) | 11.23 | % |  | 11.70 | % |  | 13.78 | % |  | 10.22 | %
Ratio of net investment (loss) income to average net assets – annualized(I) | 8.21 | % |  | 7.70 | % |  | 4.80 | % |  | 8.14 | %
(A)B ased on actual shares of common stock outstanding at the beginning or end of the corresponding period, as appropriate. (B)Based on weighted-average basic common share data for the corresponding period. (C)The tax character of distributions is determined based on taxable income calculated in accordance with income tax regulations, which may differ from amounts determined under GAAP. For further information on the estimated character of our distributions to common stockholders, including changes in estimates, as applicable, refer to Note 8 — Distributions to Common Stockholders. (D)During the three and nine months ended December 31, 2023 and 2022, the accretive effect is a result of issuing common shares at a price above the then current NAV per share. (E)Represents the impact of the different share amounts (weighted-average basic common shares outstanding for the corresponding period and actual common shares outstanding at the end of the period) in the Per Common Share Data calculations and rounding impacts. (F)Total return equals the change in the market value of our common stock from the beginning of the period, taking into account dividends reinvested in accordance with the terms of our dividend reinvestment plan. Total return does not take into account distributions that may be characterized as a return of capital. For further information on the estimated character of our distributions to common stockholders, including changes in estimates, as applicable, refer to Note 8 — Distributions to Common Stockholders. (G)Calculated using the average balance of net assets at the end of each month of the reporting period. (H)Ratio of net expenses to average net assets is computed using total expenses, net of any non-contractual, unconditional, and irrevocable credits of fees from the Adviser. Had we not received any non-contractual, unconditional, and irrevocable credits of fees from the Adviser, the ratio of expenses to average net assets - annualized would have been 14.70% and 14.24% for the three months ended December 31, 2023 and 2022, respectively, and 17.27% and 12.87% for the nine months ended December 31, 2023 and 2022, respectively. (I)Had we not received any non-contractual, unconditional, and irrevocable credits of fees from the Adviser, the ratio of net investment income (loss) to average net assets - annualized would have been 4.73% and 5.15% for the three months ended December 31, 2023 and 2022, respectively, and 1.32% and 5.50% for the nine months ended December 31, 2023 and 2022, respectively.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentCompanyAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480737/946-205-50-1 + Details
Name: | us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration